RIGL
Rigel Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$48.67
+0.35%Leverage
- Debt / equity
- 0.09x
- Net debt / equity
- -0.05x
- Debt / assets
- 0.08x
- Debt / EBITDA
- 0.42x
- Net debt / EBITDA
- -0.22x
Liquidity & coverage
- Current ratio
- 1.95x
- Quick ratio
- 1.79x
- Cash ratio
- 1.00x
- Interest coverage
- 15.00x
- EBITDA / interest
- 16.20x
- Working capital
- $90.2M
Cash & dividend
- FCF / debt
- 1.99x
- Cash flow / debt
- 1.99x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026